US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.47

-0.0895-0.36%

Post-market: 24.470.00000.00%16:10 EDT

Volume:1K

Turnover:28.67K

Market Cap:5.63M

PE:- -

High:24.55

Open:24.34

Low:24.34

Close:24.56

52wk High:27.94

52wk Low:22.89

Shares:230.00K

Float Shares:230.00K

Volume Ratio:1.73

T/O Rate:0.51%

Dividend:0.41

Dividend Rate:1.68%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

Viking Therapeutics Slips on Planned Stock, Convertible Offerings

Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

THOMSON REUTERS

Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032

THOMSON REUTERS

Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes

THOMSON REUTERS

Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors

Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15

Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial

The Stock Market is Sleeping on the Next Big AI Catalyst

Canaccord Genuity Remains a Buy on Viking Therapeutics (VKTX)

Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments

MT Newswires Live

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/THNR/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"THNR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","market":"US","secType":"STK","nameCN":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","latestPrice":24.4699,"timestamp":1791230400000,"preClose":24.5594,"halted":0,"volume":1173,"hourTrading":{"tag":"盘后","latestPrice":24.4699,"preClose":24.4699,"latestTime":"16:10 EDT","volume":7,"amount":170.98949,"timestamp":1791231005379,"change":0,"changeRate":0,"amplitude":0.006126},"delay":0,"changeRate":-0.0036442258361361036,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"Post-Mkt","change":-0.0895,"latestTime":"10-05 16:38:49 EDT","open":24.34,"high":24.5499,"low":24.34,"amount":28671,"amplitude":0.008547,"askPrice":36.83,"askSize":200,"bidPrice":12.28,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":24.5594,"sharesOutstanding":170000,"nav":24.69,"aum":5678700,"dividendRate":0.016841,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.4699,"preClose":24.4699,"latestTime":"16:10 EDT","volume":7,"amount":170.98949,"timestamp":1791231005379,"change":0,"changeRate":0,"amplitude":0.006126},"volumeRatio":1.72754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","floatShares":230000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.72754,"shares":230000,"dividePrice":0.4121,"high":24.5499,"amplitude":0.008547,"preClose":24.5594,"low":24.34,"week52Low":22.89,"pbRate":"--","week52High":27.94,"institutionHeld":0,"latestPrice":24.4699,"committee":-0.333333,"eps":0,"divideRate":0.016841,"volume":1173,"delay":0,"ttmEps":0,"open":24.34,"prevYearClose":25.22,"prevWeekClose":24.5594,"prevMonthClose":25.154,"prevQuarterClose":25.154,"fiveDayClose":25.3347,"twentyDayClose":27.0064,"sixtyDayClose":25.9299},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THNR\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"THNR","amount":0.41317273,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"THNR","amount":0.219898,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THNR\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.219898,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.41317273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THNR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THNR\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669464254","title":"U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464254?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:45","pubTimestamp":1790246700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA2Q9NDG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0385154629.USD","LU0820561909.HKD","SGXZ99366536.SGD","LU0210536198.USD","LU0320765992.SGD","IXJ","IE00BK4W5L77.USD","LU0061475181.USD","LU0225283273.USD","LU2106854487.HKD","LU2471134796.USD","GDOC","LU1804176565.USD","BK4007","LU0097036916.USD","SG9999014898.SGD","TRUH","LU0882574055.USD","LU2237443622.USD","LU1868836914.USD","LLYZ","IE0004445239.USD","LU1093756325.SGD","IE00BFSS8Q28.SGD","LU1814569148.SGD","LU2213496289.HKD","LU2237443978.SGD","LU2471134879.HKD","LU2491050154.USD","VHT","LU0943347566.SGD","IYH","LU0640476718.USD","LU2552382058.USD","IE00B4JS1V06.HKD","LU0079474960.USD","LU1267930730.SGD","LU2264538146.SGD","LU1691799644.USD","FHLC","LU1127390331.HKD","LU0432979614.USD","LU0006306889.USD","SGXZ81514606.USD","LU1551013342.USD","LU0198837287.USD","XLV","SG9999018865.SGD","LU0316494557.USD","LU1064131342.USD","LU1623119135.USD","LU1868836591.USD","SG9999015986.USD","LU0256863902.USD","SG9999001176.SGD","LU2602419157.SGD","LU2237438978.USD","LU1551013425.SGD","IE00BKDWB100.SGD","LU1868837300.USD","MEDX","IE0002141913.USD","IHE","WDNA","LU2111349929.HKD","IE00BK4W5M84.HKD","LU0345770308.USD","IE00BJT1NW94.SGD","LU2357305700.SGD","BK4599","LU0106261372.USD","LU2063271972.USD","LU2168564495.EUR","LU0109391861.USD","FTXH","LU1720051108.HKD","LU0787776722.HKD","LU0820561818.USD","LU1323610961.USD","LU0109394709.USD","LU1979441026.SGD","LU2023251221.USD","LU2750360997.AUD","LU0174119429.USD","IE00B2B36J28.USD","LU0708995401.HKD","CURE","LU2750360641.GBP","LU1868836757.USD","LU1057294990.SGD","OZEM","LU1232071149.USD","LU2360106947.USD","BK4581","LU0882574139.USD","LU0672654240.SGD","LU1629891620.HKD","BK4534","BK4585","LU0683600562.USD","LU2168564065.EUR","IE00B7KXQ091.USD","GB00BDT5M118.USD","LU0266013472.USD","IE00BWXC8680.SGD","LU2361044865.SGD","LU0786609619.USD","LU2271345857.HKD","LU2552382215.SGD","IE0001KFT4U8.USD","LU2108987350.USD","SG9999013999.USD","SG9999017495.SGD","LU1988902786.USD","CANC","LU2087625088.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","LU0823434583.USD","BK4516","LU2746668461.USD","LU2112291526.USD","LU1280957306.USD","LU0238689110.USD","LU0114720955.EUR","LU2361045086.USD","LLY","LU2491049909.HKD","LU2462591350.SGD","LU2211815571.USD","LU0823416689.USD","IE0005OL40V9.USD","LU0354030438.USD","LU1720051017.SGD","THNR","LU2756315318.SGD","LU2461242641.AUD","LU1974910355.USD","IE00BKPKM429.USD","LU1035775433.USD","LU1983299246.USD","SG9999015978.USD","ELIL","LU0689472784.USD","LU1145028129.USD","LU2237443465.HKD","SG9999001176.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU0096364046.USD","IE00BJLML261.HKD","LU2456880835.USD","LU2468319806.SGD","SG9999018857.SGD","LU0823434740.USD","LU2417539215.USD","LU2023250504.SGD","SG9999014880.SGD","SG9999015952.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU1093756168.USD","BK4588","LU2896262040.SGD","IE0004445015.USD","PJP","LU1291159041.SGD","LU1366192091.USD","LU2168563687.JPY","ILDR","LU0289739699.SGD","SG9999014914.USD","LU0323591593.USD","LU0234572021.USD","LLII","HRTS","LU2746668974.SGD","SGXZ51526630.SGD","SGXZ31699556.SGD","IE00BFSS7M15.SGD","LU0353189763.USD","SG9999014906.USD","LU0353189680.USD","LU1023059063.AUD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU0417517546.SGD","LU2028103732.USD","IE00BJJMRY28.SGD","LU0345770993.USD","LU0889565916.HKD","LU2237443382.USD","LU0471298777.SGD","LU1712237335.SGD","BK4533","LU2756315664.SGD","LU2236285917.USD","AGNG","LU2265009873.SGD","LU2462157665.USD","PPH","JDOC","IE00B775H168.HKD","SG9999015945.SGD","IE00BJJMRX11.SGD","LU1069344957.HKD","IE00BN29S564.USD","LLYX","LU2237443549.SGD","LU2168564149.EUR","LU1868837136.USD","LU2089284900.SGD","LU2491050071.SGD","LU0158827948.USD","LU0256863811.USD","LU2089984988.USD","LU2237443895.HKD","LU0158827781.USD","LU2023250330.USD","LU0466842654.USD","LU0471298694.HKD","LU0354030511.USD","ELIS","LU2168564222.USD","RXL","LU0133085943.USD","MEDI","LU0820562030.AUD","LU0320765059.SGD","LU0203201768.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","MHIP","LU1548497426.USD","LU2361044949.HKD","LU0964807845.USD","TMED","LU0122379950.USD","LU0203202063.USD","LU1061106388.HKD","LU1917777945.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU2471134523.USD","IE0009355771.USD","LU0094547139.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191747742","title":"Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1191747742","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191747742?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:51","pubTimestamp":1790239896,"startTime":"0","endTime":"0","summary":"The key takeaway is that Novo Nordisk laid out ambitious goals on Monday, planning to launch at least five potential blockbuster drugs by 2030, yet its share price plunged 8% after the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","NVO","NVOC","NVOH","LU1093756325.SGD","NVOX","BK4599","OZEM","LU1093756168.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","THNR","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669468530","title":"Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2669468530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669468530?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:03","pubTimestamp":1790237015,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","BK4599","VKTX","BK4585","OZEM","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669458471","title":"RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669458471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669458471?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:45","pubTimestamp":1790214356,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Trung Huynh maintained a Buy rating on Eli Lilly & Co on September 21 and set a price target of $1,500.00. The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-eli-lilly-co-lly-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-eli-lilly-co-lly-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BK4W5M84.HKD","LU1064131342.USD","LU1057294990.SGD","LU0345770993.USD","LU2456880835.USD","LU0943347566.SGD","LU0354030438.USD","LU0820561909.HKD","LU0234572021.USD","SG9999018865.SGD","GDOC","LU0114720955.EUR","LU0964807845.USD","LU2023250330.USD","LU2746668974.SGD","LU2236285917.USD","LU2361045086.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0094547139.USD","BK4007","LU0456855351.SGD","SGXZ51526630.SGD","ILDR","LU1868837300.USD","LU0672654240.SGD","LLYZ","LU0466842654.USD","LU2213496289.HKD","LU2361044949.HKD","LU0320765992.SGD","LU2746668461.USD","GB00BDT5M118.USD","LU1093756168.USD","SG9999015952.SGD","BK4581","SG9999018857.SGD","WDNA","LU2471134523.USD","LLY","LU2552382132.HKD","LU1035775433.USD","BK4534","IXJ","LU2361044865.SGD","SG9999014914.USD","LU1061106388.HKD","OZEM","LU2552382215.SGD","LU0708995401.HKD","LU1974910355.USD","IE0005OL40V9.USD","BK4533","LU0266013472.USD","LU0882574055.USD","LU2750360641.GBP","HRTS","LU2168564065.EUR","LU1989771016.USD","SG9999014880.SGD","CURE","LU1868836591.USD","LU1548497426.USD","IE00BFSS8Q28.SGD","LU0096364046.USD","LU0198837287.USD","IE00BKPKM429.USD","LU0385154629.USD","LU2063271972.USD","LU0689472784.USD","LU2089284900.SGD","IE00BN29S564.USD","XLV","LU1291159041.SGD","IE00BFSS7M15.SGD","LU0256863902.USD","AGNG","IE0001KFT4U8.USD","LU2168563687.JPY","LU2756315318.SGD","IE00B1XK9C88.USD","SG9999001176.SGD","IE00BK4W5L77.USD","ELIS","IE0004445239.USD","LU0061475181.USD","BK4588","LU1868836757.USD","LU2023251221.USD","SGXZ81514606.USD","LU0058720904.USD","TMED","LU0353189680.USD","LU2271345857.HKD","LU0225283273.USD","LU0320765059.SGD","SG9999017495.SGD","LU0432979614.USD","LU2461242641.AUD","LU2896262040.SGD","BK4599","LU1551013342.USD","LU1280957306.USD","LU0787776722.HKD","LU0353189763.USD","LU0106261372.USD","LU1629891620.HKD","LU2237438978.USD","IE00BWXC8680.SGD","LU0323591593.USD","IE00B7KXQ091.USD","LU1814569148.SGD","LU1712237335.SGD","SG9999014906.USD","IE00BJJMRY28.SGD","IYH","LU0471298694.HKD","LU2750360997.AUD","LU0823434740.USD","LU0640476718.USD","LU1127390331.HKD","LU2089283258.USD","RXL","SGXZ57979304.SGD","LU0316494557.USD","LU2168564222.USD","LU2237443622.USD","SGXZ31699556.SGD","LU2491050071.SGD","TRUH","LU0109394709.USD","LU2264538146.SGD","LU0210536198.USD","LU0354030511.USD","LU1868836914.USD","LU2089984988.USD","LU2357305700.SGD","LU2462157665.USD","CANC","LU0882574139.USD","LU1979441026.SGD","LU2211815571.USD","IE00B4JS1V06.HKD","IE0004445015.USD","LU1093756325.SGD","LLYX","IE00B775H168.HKD","IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU1023059063.AUD","LU1983299246.USD","LU1623119135.USD","SG9999001176.USD","SG9999014898.SGD","LU1366192091.USD","LU0889565916.HKD","LU0158827781.USD","LU0174119429.USD","FTXH","LU1069344957.HKD","LU2112291526.USD","MEDI","SG9999013999.USD","LU2756315664.SGD","LU2111349929.HKD","LU0203201768.USD","BK4585","LU0256863811.USD","LU1232071149.USD","LU2491049909.HKD","LU0097036916.USD","LU2471134796.USD","LU0823434583.USD","PPH","LU0109391861.USD","IE00BJLML261.HKD","LU0345770308.USD","LU2237443465.HKD","LU2237443895.HKD","LU0820561818.USD","LU2237443978.SGD","LU1323610961.USD","SG9999015978.USD","IE0002141913.USD","LU2106854487.HKD","LU0823416689.USD","IHE","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU2087625088.SGD","LU2168564495.EUR","MEDX","LU2028103732.USD","LU0203202063.USD","LU0683600562.USD","LLII","LU0158827948.USD","LU2491050154.USD","LU2602419157.SGD","LU1917777945.USD","LU2417539215.USD","LU1720051017.SGD","LU0820562030.AUD","LU1267930730.SGD","JDOC","IE00BJT1NW94.SGD","LU2237443382.USD","LU2265009873.SGD","THNR","LU2168564149.EUR","LU2552382058.USD","LU0122379950.USD","LU1145028129.USD","VHT","LU2237443549.SGD","PJP","LU0133085943.USD","LU0238689110.USD","LU1691799644.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU1988902786.USD","LU0289739699.SGD","LU2324357040.USD","SG9999015945.SGD","LU1551013425.SGD","IE0009355771.USD","LU2023250504.SGD","LU2108987350.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","FHLC","IE00B4R5TH58.HKD","LU0079474960.USD","LU1804176565.USD","LU1868837136.USD","LU0006306889.USD","LU2462591350.SGD","MHIP","SG9999015986.USD","LU1720051108.HKD","LU2471134952.CNY","BK4516","IE00BFTCPJ56.SGD","LU2360106947.USD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431849","title":"Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431849?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:15","pubTimestamp":1790198123,"startTime":"0","endTime":"0","summary":"Morgan Stanley and JPMorgan are acting as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-ti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-200m-spot-secondary-price-range-35-00-38-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-200m-spot-secondary-price-range-35-00-38-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VFH","TRUF","LU0106831901.USD","XLF","LU0557290698.USD","IE00BDCRKT87.USD","LU0496365809.HKD","BK4588","LU0234572021.USD","BK4533","LU1244550494.USD","FTXO","BK4139","UYG","IXG","IAI","IE000MB6IJN5.SGD","LU0211327993.USD","LU1074936037.SGD","LU0795875086.SGD","BK4504","LU0964807845.USD","LU2237443549.SGD","LU1791710582.SGD","IYG","LU0912757837.SGD","LU2357627491.SGD","LU2168564149.EUR","LU1720051017.SGD","OZEM","LU2430703178.SGD","THNR","LU2237443895.HKD","VKTX","LU0417517546.SGD","TFNS","FNCL","LU2111349929.HKD","IYF","LU0211328371.USD","KBWB","BK4599","IE00BK4W5M84.HKD","LU1116320901.HKD","JPMO","LU1267930490.SGD","PGF","LU1280957306.USD","JPO","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669439523","title":"Viking Therapeutics Slips on Planned Stock, Convertible Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2669439523","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669439523?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:01","pubTimestamp":1790197296,"startTime":"0","endTime":"0","summary":"BUZZ-Viking Therapeutics slips on planned stock, convertible offerings** Shares of Viking TherapeuticsVKTX.Odown 8% at $38.32 post-market as co looks to raise capital** VKTX announces public offerings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F168:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","IE000MB6IJN5.SGD","LU2237443549.SGD","LU0149725797.USD","LU2106854487.HKD","LU1914381329.SGD","LU0557290698.USD","JPMO","IE00BK4W5M84.HKD","LU2756315318.SGD","IYF","LU2347655156.SGD","LU0070302665.USD","LU2357627491.SGD","OZEM","LU0882574139.USD","UYG","VFH","IE00BFXG1179.USD","LU2264538146.SGD","IXG","LU2023250330.USD","IE00BDCRKT87.USD","TRUF","XLF","LU2028103732.USD","JPO","BK4207","LU0234572021.USD","FNCL","LU0345770308.USD","LU1363072403.SGD","IE00BJTD4V19.USD","LU0912757837.SGD","THNR","TFNS","LU0345769128.USD","FTXO","VKTX","LU0048584097.USD","LU0211328371.USD","IAI","LU1732799900.SGD","LU2023250843.SGD","SG9999002224.SGD","LU2237443895.HKD","LU1670628061.USD","LU0971096721.USD","IYG","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143641","title":"Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143641","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143641?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195616,"startTime":"0","endTime":"0","summary":"Viking Therapeutics plans USD 200 million convertible senior notes offering due 2032Viking Therapeutics launched a public offering of USD 200 million convertible senior notes due 2032.Underwriters hol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL8YlXBZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VKTX","BK4588","BK4585","OZEM","BK4599","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436418","title":"Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436418?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195595,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JVKDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","OZEM","VKTX","BK4139","BK4599","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436413","title":"Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436413?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JVKDZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","VKTX","BK4585","BK4139","BK4599","THNR","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669364904","title":"Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669364904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669364904?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:33","pubTimestamp":1790195595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JVKDZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","THNR","BK4585","OZEM","BK4139","VKTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436230","title":"Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436230?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:31","pubTimestamp":1790195460,"startTime":"0","endTime":"0","summary":"DJ Eli Lilly & Co. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Eli Lilly & Co.  slipped 1.64% to $1,150.99 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.75% to 7,706.03 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.The stock's fall snapped a five-day winning streak.Eli Lilly & Co. closed 10.96% short of its 52-week high of $1,292.65, which the company achieved on August 19th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.01% to $269.17, Pfizer Inc.  rose 0.90% to $28.18, and AbbVie Inc.  fell 0.05% to $265.08.Trading volume  remained 443,603 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2023251221.USD","LU2168564149.EUR","LU1623119135.USD","LU1868836914.USD","RXL","LU2471134796.USD","LU0097036916.USD","LU2168564065.EUR","LU0266013472.USD","LU0256863811.USD","LU0823416689.USD","LU0943347566.SGD","IE00BKDWB100.SGD","HRTS","IE00BFSS7M15.SGD","LU0820562030.AUD","LU1989771016.USD","LU0210536198.USD","LU1814569148.SGD","LU2237438978.USD","LU0823434583.USD","LU0345770308.USD","LU0158827948.USD","SG9999014898.SGD","LU2237443978.SGD","LU1280957306.USD","LU2237443382.USD","THNR","IE00B775H168.HKD","LU2168564495.EUR","FTXH","BK4585","LLYX","LU0320765059.SGD","IE0009355771.USD","IE00BKPKM429.USD","LU1023059063.AUD","LU0471298777.SGD","IE00BFSS8Q28.SGD","SG9999017495.SGD","MHIP","BK4007","LU0058720904.USD","LU1868836757.USD","LU2089283258.USD","LU2211815571.USD","LU2461242641.AUD","LU0079474960.USD","LU0203202063.USD","GB00BDT5M118.USD","LU2112291526.USD","LU2028103732.USD","LU0133085943.USD","LU1093756168.USD","LU2168563687.JPY","LU1979441026.SGD","LU1720051017.SGD","SGXZ99366536.SGD","LU1691799644.USD","IE00B7KXQ091.USD","LU0889565916.HKD","LU0316494557.USD","LU2552382058.USD","PJP","LU1323610961.USD","LU1868837136.USD","LU2213496289.HKD","TRUH","LU2746668461.USD","BK4534","LLY","ELIL","BK4581","LU2023250330.USD","SG9999014914.USD","LU0385154629.USD","AGNG","LU1291159041.SGD","LU2089984988.USD","SG9999014906.USD","LU1917777945.USD","LU1974910355.USD","MEDI","LU2471134879.HKD","SG9999001176.SGD","LU2063271972.USD","LU0106261372.USD","LU0320765992.SGD","BK4516","GDOC","LU0174119429.USD","LU2491049909.HKD","LU0432979614.USD","LU0234572021.USD","IE0002141913.USD","LU0096364046.USD","LU1629891620.HKD","LU0109394709.USD","LU0323591593.USD","LU2237443549.SGD","LU2491050154.USD","LU2602419157.SGD","LU2168564222.USD","LU2361045086.USD","LU0683600562.USD","SG9999001176.USD","SG9999018857.SGD","ILDR","LU1093756325.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU0122379950.USD","CANC","LU1983299246.USD","VHT","IE0004445015.USD","BK4533","LU0417517546.SGD","LU0823434740.USD","LU2108987350.USD","LU2237443895.HKD","LU2265009873.SGD","IYH","LU0787776722.HKD","SGXZ81514606.USD","IE00BJT1NW94.SGD","LU0354030438.USD","LU2471134952.CNY","LU2087625088.SGD","LU0345770993.USD","LU2271345857.HKD","LU0640476718.USD","LU1804176565.USD","LU2468319806.SGD","LU2236285917.USD","LU2750360641.GBP","IHE","PPH","IE00BN29S564.USD","LU0964807845.USD","SG9999015986.USD","LU0353189763.USD","WDNA","LU0689472784.USD","LU2456880835.USD","LU0006306889.USD","LLYZ","LU1988902786.USD","IE00BJJMRZ35.SGD","LU2756315318.SGD","LU2746668974.SGD","SGXZ57979304.SGD","LU2089284900.SGD","LU0061475181.USD","IE00B1XK9C88.USD","LU0708995401.HKD","LU2462591350.SGD","LU1035775433.USD","BK4588","LU0820561818.USD","LU2237443622.USD","LU2106854487.HKD","LU2471134523.USD","LU2360106947.USD","LU1548497426.USD","FHLC","LU2237443465.HKD","LU0353189680.USD","LU2111349929.HKD","LU2357305700.SGD","LU2361044865.SGD","SGXZ31699556.SGD","IE00B4R5TH58.HKD","IE00BWXC8680.SGD","LU0225283273.USD","LU1145028129.USD","LU1868836591.USD","LU1061106388.HKD","LLII","IE00B4JS1V06.HKD","CURE","LU0786609619.USD","LU1366192091.USD","LU1720051108.HKD","LU2491050071.SGD","LU2552382132.HKD","LU2552382215.SGD","OZEM","LU2361044949.HKD","LU0882574055.USD","LU0466842654.USD","LU0672654240.SGD","IE00BFTCPJ56.SGD","LU0354030511.USD","LU1868837300.USD","LU1064131342.USD","LU2417539215.USD","MEDX","LU0456855351.SGD","IE00BJLML261.HKD","LU0820561909.HKD","IE00BK4W5L77.USD","LU0158827781.USD","IXJ","SG9999013999.USD","LU1232071149.USD","IE0001KFT4U8.USD","XLV","IE00BJJMRX11.SGD","IE00BK4W5M84.HKD","LU0882574139.USD","LU0198837287.USD","SG9999015952.SGD","SG9999018865.SGD","LU0256863902.USD","LU2756315664.SGD","SG9999015978.USD","TMED","IE0004445239.USD","BK4599","LU0238689110.USD","LU1267930730.SGD","IE0005OL40V9.USD","SG9999015945.SGD","ELIS","IE00BJJMRY28.SGD","LU1551013342.USD","LU0109391861.USD","IE00B1BXHZ80.USD","SGXZ51526630.SGD","LU0471298694.HKD","LU1712237335.SGD","LU2264538146.SGD","LU2896262040.SGD","LU0114720955.EUR","LU1069344957.HKD","LU1127390331.HKD","LU0289739699.SGD","LU2750360997.AUD","LU1551013425.SGD","LU2023250504.SGD","LU0094547139.USD","JDOC","SG9999014880.SGD","LU2462157665.USD","LU0203201768.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436685","title":"Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436685","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436685?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:17","pubTimestamp":1790194672,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe sells 29,277 common shares for $876,846.15Hims & Hers Health CFO Oluyemi Okupe sold 29,277 Class A shares on Sept. 22 at USD 29.95.Okupe exercised options for 14,000 shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL8NjRcH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","HMYY","THNR","GLAM","HIMY","BK4196","HIMS","HEAL","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436112","title":"Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436112","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436112?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:15","pubTimestamp":1790194525,"startTime":"0","endTime":"0","summary":"• Novo Nordisk shares dropped following disappointing long-term revenue growth targets.\n• Intensifying competition, patent cliff risks, and market share losses weighed heavily.\n• Technical indicators show sell signals with an RSI of 27.877.","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262183539-market-movers-nvo-20260923","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","BK4585","BK4532","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOX","BK4588","OZEM","IE00BKVL7J92.USD","BK4007","NVO","NVOC","THNR","BK4599","LU0154236417.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669791487","title":"Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2669791487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669791487?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:02","pubTimestamp":1790179320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 2.5% to DKK252.25 Wednesday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.8% to 2,648.31.This was the stock's third consecutive day of losses.The company closed DKK157.70 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,754,249, compared to the 50-day average trading volume of 4,611,738.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","PPH","BK4585","LU0154236417.USD","LU1093756168.USD","NVOX","BK4532","LU1093756325.SGD","NVOC","IE00BZ1G4Q59.USD","NVOH","OZEM","THNR","BK4007","NVO","BK4588","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669826694","title":"Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669826694","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669826694?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:40","pubTimestamp":1790174414,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) this week announced topline results from the phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly CagriSema, an investigatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-cagrisema-delivers-superior-weight-loss-in-reimagine-5-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-cagrisema-delivers-superior-weight-loss-in-reimagine-5-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756325.SGD","BK4599","BK4585","LU1093756168.USD","NVOX","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","NVO","BK4007","THNR","NVOH","NVOC","LU0154236417.USD","OZEM","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669884054","title":"The Stock Market is Sleeping on the Next Big AI Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2669884054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669884054?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:37","pubTimestamp":1790163420,"startTime":"0","endTime":"0","summary":"Fed's Barkin warns that inflation is a 'troublemaker'Inflation is proving to be a \"troublemaker\" for the central bank, according to Richmond Fed President Tom Barkin, who told the CFA Society of Baltimore that inflationary pressures from businesses struggling with higher operating costs are still building in some areas. Read more about what could come next here.&#128241; Meta's Muse is stirring up AI disruption fearsFears are spiraling that Meta Platforms' new Muse AI model could disrupt a variety of industries ahead of the tech giant's Connect conference today and tomorrow. The virtual personal assistant can do a variety of tasks including booking appointments and travel, ordering items on retail sites, choosing insurance, and set up stock trades.&#128137; Lilly and Novo aren't the only weight-loss game in townThe success of Eli Lilly and Novo Nordisk in the weight loss drug realm is attracting newer entrants, including Viking Therapeutics, which just got some positive test resu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTE","NVOH","AAPX","QTOC","AIPO","AIS","AAPU","FXL","MRVL","ARTY","VKTX","ABFL","WUGI","FCOM","VOX","VT","METU","AAPL","NULC","LTL","SMHX","VTHR","XLC","XNTK","AIFD","MVLL","RSPC","META","CMAG","NVO","THNR","OGIG","FDTX","METV","GAMR","GXPC","CHAT","FAI","SOXY","SAAPLmain","NVOX","APLY","AAPW","AGIX","SMETAmain","MRVU","GTEK","XDAT","JGRO","AAPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648839","title":"Canaccord Genuity Remains a Buy on Viking Therapeutics (VKTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648839?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:16","pubTimestamp":1790162192,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Nash from Canaccord Genuity reiterated a Buy rating on Viking Therapeutics, with a price target of $114.00. Acco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-viking-therapeutics-vktx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-viking-therapeutics-vktx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","VKTX","BK4585","BK4139","THNR","BK4588","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669109600","title":"Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments","url":"https://stock-news.laohu8.com/highlight/detail?id=2669109600","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669109600?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:39","pubTimestamp":1790152792,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has won approval from Singapore authorities for the use of its weight-loss drug, Wegovy, to treat certain liver diseases, the drugmaker said Wednesday.Wegovy, a once-weekly injectab","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPH","BK4532","NVO","BK4588","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","OZEM","BK4599","BK4007","LU0154236417.USD","BK4585","THNR","NVOC","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177534","title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177534","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177534?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:21","pubTimestamp":1790151673,"startTime":"0","endTime":"0","summary":"UPDATE 1-Novo Nordisk open to direct New York listing, CEO Doustdar tells FTSept 23 (Reuters)-Novo NordiskNOVOb.COis open to considering a direct New York Stock Exchange listing, replacing the America","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F05A:2","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","MEDX","OZEM","ILDR","LU1023059063.AUD","IHE","LU1623119135.USD","LU2324357040.USD","MEDI","NVOH","GDOC","NVO","IE00BFTCPJ56.SGD","CANC","IYH","FTXH","TMED","FHLC","LU2471134796.USD","MHIP","HRTS","LU0640476718.USD","LU1868836591.USD","PJP","JDOC","IE0009355771.USD","XLV","LU0133085943.USD","WDNA","LU2028103732.USD","NVOX","TRUH","THNR","SGXZ99366536.SGD","LU0320765992.SGD","RXL","LU2462157665.USD","VHT","LU0345770308.USD","AGNG","CURE","IXJ","PPH","LLYZ","LU0114720955.EUR","IE00BJJMRY28.SGD","LU0354030511.USD","LU2168564065.EUR","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669106133","title":"Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2669106133","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669106133?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:05","pubTimestamp":1790150726,"startTime":"0","endTime":"0","summary":"Novo Nordisk  signaled it may consider upgrading its New York listing as it looks to raise its profile in the US market, the Financial Times reported Wednesday, citing chief executive Mike Doustdar.Doustdar said he sees potential advantages in listing shares directly on the New York Stock Exchange rather than relying on American depositary receipts, though the company is not actively pursuing the move, according to the FT.The US accounts for more than half of Novo's revenue and most of its sales of diabetes and obesity treatments, according to the report.Novo Nordisk did not immediately respond to MT Newswires' request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU1093756325.SGD","BK4599","BK4585","LU1093756168.USD","NVOX","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","NVO","BK4007","THNR","NVOH","NVOC","LU0154236417.USD","OZEM","PPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":8,"totalSize":211,"code":"91000000","status":"200"}]}}